Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy
American Association for the Advancement of Science (AAAS) -- Science Advances
DOI 10.1126/sciadv.aay7785
Abstract(s)

A potent drug delivery strategy promotes tumor infiltration of T cells and unleashes antitumor immunity.